FOXO3 and hepatocellular carcinoma: In line with our findings, miR-223 has also been shown to target FOXO3-induced autophagy and rescue doxorubicin sensitivity in HCC [18], while osteopontin elicited epirubicin and cisplatin resistance through the upregulation of FOXO3-dependent autophagy [19].